Related Experiment Video
Updated: Jun 19, 2026

09:43
Measurement of Heme Synthesis Levels in Mammalian Cells
Published on: July 9, 2015
GLOBIN UTILIZATION BY THE ANEMIC DOG TO FORM NEW HEMOGLOBIN
F S Robscheit-Robbins1, G H Whipple
1Department of Pathology, The University of Rochester School of Medicine and Dentistry, Rochester, N. Y.
The Journal of Experimental Medicine
|October 30, 2009
Summary
Anemic dogs can synthesize new hemoglobin from various sources, including intravenously administered hemoglobin and orally ingested globin. However, intravenous globin can inhibit hemoglobin formation due to toxicity.
Area of Science:
- Biochemistry
- Hematology
- Animal Physiology
Background:
- Anemia, particularly that caused by blood loss, presents challenges in hemoglobin regeneration.
- Understanding the metabolic fate of hemoglobin components is crucial for developing effective treatments.
Purpose of the Study:
- To investigate the utilization of hemoglobin and globin by anemic dogs for new hemoglobin synthesis.
- To determine the efficacy of different administration routes and sources of globin.
Main Methods:
- Anemic dogs were intravenously administered sheep, goose, or dog hemoglobin.
- Globin and digested globin were administered intravenously and orally.
- Hemoglobin regeneration and globin utilization were quantitatively assessed.
Main Results:
- Anemic dogs quantitatively converted intravenously administered hemoglobin into new dog hemoglobin.
- Intravenous globin administration sometimes led to new hemoglobin formation but could also inhibit it, suggesting toxicity.
- Digested globin and orally administered globin were effectively utilized for hemoglobin synthesis, with 30-40% utilization from oral globin.
- Oral globin utilization surpassed that of liver protein (13% utilization).
Conclusions:
- The globin component of hemoglobin is a significant factor in hemoglobin production for anemic dogs.
- Oral administration of globin represents a viable and efficient method for promoting hemoglobin synthesis in cases of anemia.
Related Concept Videos
Hemoglobin
Hemoglobin is a globular protein made up of four subunits. Two of these subunits are alpha chains, and the other two are beta chains. Each subunit contains a molecule of heme, which has an iron atom and can bind to oxygen. When an oxygen molecule binds to one heme group, it changes the shape of hemoglobin, making it easier for the other heme groups to bind oxygen as well.
When all four heme groups are bound to oxygen, the resulting molecule is called oxyhemoglobin. As a result, arterial blood...
When all four heme groups are bound to oxygen, the resulting molecule is called oxyhemoglobin. As a result, arterial blood...
Oxygen Transport in the Blood
Hemoglobin (Hb) is a crucial molecule in the human body, consisting of four polypeptide chains, each bound to an iron-containing heme group. This unique structure enables hemoglobin to bind to oxygen, with each molecule capable of combining with four molecules of oxygen, leading to rapid and reversible oxygen loading. When fully loaded with oxygen, it is called oxyhemoglobin, while hemoglobin that has released oxygen is called reduced hemoglobin or deoxyhemoglobin. As hemoglobin binds oxygen,...
Erythropoiesis
Red blood cells (RBCs) transport oxygen to all body tissues. These cells survive only for 120 days and then need to be replenished. Erythropoiesis is the process of RBC production. In healthy individuals, erythropoiesis ensures all tissues are amply supplied with oxygen. In addition, blood loss due to injury leads to a drop in the physiological oxygen level that will cause erythropoiesis. Any defect in erythropoiesis leads to several physiological disorders, including thalassemia, anemia, and...
Lifecycle of Erythrocytes
Erythrocytes, also known as red blood cells, constantly move through blood capillaries. As a result, they damage their plasma membrane due to the continuous friction. Typically, after 100 to 120 days, erythrocytes become rigid and fragile as they wear out. As they pass through small vessels in the spleen and liver, they can get trapped and break apart into fragments.
The resident phagocytic macrophages deal with these damaged cells by engulfing them and separating their globin and heme groups.
The resident phagocytic macrophages deal with these damaged cells by engulfing them and separating their globin and heme groups.
Disorders of Erythrocytes
Disorders of erythrocytes, or red blood cells (RBCs), include a range of conditions affecting their number, shape, or function.
Erythrocyte disorders can be broadly categorized into two main types: anemic and polycythemic conditions.
A low oxygen-carrying capacity of the blood due to the loss, lower production, or destruction of erythrocytes is termed anemia. Hemorrhagic anemia, for example, occurs when bleeding from an external wound or internal ulcer reduces erythrocyte counts.
On the other...
Erythrocyte disorders can be broadly categorized into two main types: anemic and polycythemic conditions.
A low oxygen-carrying capacity of the blood due to the loss, lower production, or destruction of erythrocytes is termed anemia. Hemorrhagic anemia, for example, occurs when bleeding from an external wound or internal ulcer reduces erythrocyte counts.
On the other...
Factors Affecting Erythropoiesis
The cardiovascular system regulates the number of erythrocytes in the bloodstream to ensure optimal oxygen transport. It also prevents over-proliferation of these cells, which helps to maintain blood viscosity and flow rate.
Several factors influence the erythrocyte production rate, with tissue oxygen level being among the most critical. Intense exercise or high altitudes can cause tissue hypoxia, which triggers the kidneys to release more erythropoietin (EPO) into the bloodstream.
EPO then...
Several factors influence the erythrocyte production rate, with tissue oxygen level being among the most critical. Intense exercise or high altitudes can cause tissue hypoxia, which triggers the kidneys to release more erythropoietin (EPO) into the bloodstream.
EPO then...

